IMNC UMR 8165 CNRS-Paris 7 and Paris 11 Universities, Orsay, France.
J Nucl Med. 2010 Feb;51(2):268-76. doi: 10.2967/jnumed.109.066241. Epub 2010 Jan 15.
In (18)F-FDG PET, tumors are often characterized by their metabolically active volume and standardized uptake value (SUV). However, many approaches have been proposed to estimate tumor volume and SUV from (18)F-FDG PET images, none of them being widely agreed upon. We assessed the accuracy and robustness of 5 methods for tumor volume estimates and of 10 methods for SUV estimates in a large variety of configurations.
PET acquisitions of an anthropomorphic phantom containing 17 spheres (volumes between 0.43 and 97 mL, sphere-to-surrounding-activity concentration ratios between 2 and 68) were used. Forty-one nonspheric tumors (volumes between 0.6 and 92 mL, SUV of 2, 4, and 8) were also simulated and inserted in a real patient (18)F-FDG PET scan. Four threshold-based methods (including one, T(bgd), accounting for background activity) and a model-based method (Fit) described in the literature were used for tumor volume measurements. The mean SUV in the resulting volumes were calculated, without and with partial-volume effect (PVE) correction, as well as the maximum SUV (SUV(max)). The parameters involved in the tumor segmentation and SUV estimation methods were optimized using 3 approaches, corresponding to getting the best of each method or testing each method in more realistic situations in which the parameters cannot be perfectly optimized.
In the phantom and simulated data, the T(bgd) and Fit methods yielded the most accurate volume estimates, with mean errors of 2% +/- 11% and -8% +/- 21% in the most realistic situations. Considering the simulated data, all SUV not corrected for PVE had a mean bias between -31% and -46%, much larger than the bias observed with SUV(max) (-11% +/- 23%) or with the PVE-corrected SUV based on T(bgd) and Fit (-2% +/- 10% and 3% +/- 24%).
The method used to estimate tumor volume and SUV greatly affects the reliability of the estimates. The T(bgd) and Fit methods yielded low errors in volume estimates in a broad range of situations. The PVE-corrected SUV based on T(bgd) and Fit were more accurate and reproducible than SUV(max).
在(18)F-FDG PET 中,肿瘤通常以其代谢活跃的体积和标准化摄取值(SUV)为特征。然而,已经提出了许多从(18)F-FDG PET 图像估计肿瘤体积和 SUV 的方法,但是没有一种方法被广泛认可。我们评估了 5 种肿瘤体积估计方法和 10 种 SUV 估计方法在各种配置中的准确性和稳健性。
使用包含 17 个球体(体积在 0.43 到 97 毫升之间,球体与周围活性浓度比在 2 到 68 之间)的拟人化体模进行 PET 采集。还模拟了 41 个非球形肿瘤(体积在 0.6 到 92 毫升之间,SUV 为 2、4 和 8),并将其插入真实患者的(18)F-FDG PET 扫描中。文献中描述的 4 种基于阈值的方法(包括一种考虑背景活动的 T(bgd)方法)和一种基于模型的方法(Fit)用于肿瘤体积测量。在没有和没有部分容积效应(PVE)校正的情况下计算得到的体积中的平均 SUV,以及最大 SUV(SUV(max))。使用 3 种方法优化了肿瘤分割和 SUV 估计方法中的参数,这些方法分别对应于获得每种方法的最佳效果,或在参数不能完全优化的更现实情况下测试每种方法。
在体模和模拟数据中,T(bgd)和 Fit 方法产生了最准确的体积估计,在最现实的情况下,平均误差为 2% +/- 11% 和 -8% +/- 21%。考虑到模拟数据,所有未经 PVE 校正的 SUV 的平均偏差在-31%到-46%之间,远远大于用 SUV(max)(-11% +/- 23%)或基于 T(bgd)和 Fit 的 PVE 校正 SUV(-2% +/- 10%和 3% +/- 24%)观察到的偏差。
用于估计肿瘤体积和 SUV 的方法极大地影响了估计的可靠性。在广泛的情况下,T(bgd)和 Fit 方法对体积估计的误差较小。基于 T(bgd)和 Fit 的 PVE 校正 SUV 比 SUV(max)更准确和可重复。